These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3526020)

  • 1. [Optimum time of insulin therapy in type I diabetes mellitus].
    Vílchez Joya R; Miguel B; Sánchez-Cantalejo E; Luna J; Corpas MS
    Med Clin (Barc); 1986 Jul; 87(6):228-30. PubMed ID: 3526020
    [No Abstract]   [Full Text] [Related]  

  • 2. Early preprandial hypoglycemia after administration of insulin lispro.
    Iafusco D; Angius E; Prisco F
    Diabetes Care; 1998 Oct; 21(10):1777-8. PubMed ID: 9773751
    [No Abstract]   [Full Text] [Related]  

  • 3. Morning peripheral insulin effectiveness and night changes in growth hormone, blood glucose and basal insulin needs in patients with type 1 diabetes mellitus.
    Borissova AM; Kozlovski P; Popova J; Kirilov G
    Diabete Metab; 1992; 18(6):463-4. PubMed ID: 1297604
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intensified insulin therapy. References for general practice for increased control].
    Dreyer M
    MMW Fortschr Med; 2000 May; 142(21):42-4, 46, 48 passim. PubMed ID: 10872294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study.
    Pozzilli P; Manfrini S; Buzzetti R; Lampeter E; Leeuw ID; Iafusco D; Prisco M; Ionescu-Tirgoviste C; Kolouskovà S; Linn T; Ludvigsson J; Madàcsy L; Mrozikiewicz AS; Mrozikiewicz PM; Podar T; Vavrinec J; Vialettes B; Visalli N; Yilmaz T; Browne PD;
    Diabetes Res Clin Pract; 2005 Jun; 68(3):258-64. PubMed ID: 15936469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Elimination of the instability of blood glucose level as a measure of increasing the effectiveness of insulin therapy in insulin-dependent diabetes mellitus].
    Tikhonova EP
    Ter Arkh; 1989; 61(2):81-4. PubMed ID: 2658195
    [No Abstract]   [Full Text] [Related]  

  • 7. Minimal influence of the time interval between injection of regular insulin and food intake on blood glucose control of type 1 diabetic patients on a basal-bolus insulin scheme.
    Scheen AJ; Letiexhe MR; Lefèbvre PJ
    Diabetes Metab; 1999 Jun; 25(2):157-62. PubMed ID: 10443327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of blood glucose levels in patients with type 1 diabetes mellitus on intensified insulin regimens.
    Moberg EA; Lins PE; Adamson UK
    Diabete Metab; 1994; 20(6):546-52. PubMed ID: 7713278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of twice-daily insulin regimes in insulin-dependent diabetic children.
    Tan SH; Lee BW
    J Singapore Paediatr Soc; 1983; 25(1-2):70-4. PubMed ID: 6355656
    [No Abstract]   [Full Text] [Related]  

  • 10. Twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn therapy for newly diagnosed type 1 diabetes.
    Al Shamsi AM
    Pediatrics; 2008 Sep; 122(3):675-6; author reply 676. PubMed ID: 18762540
    [No Abstract]   [Full Text] [Related]  

  • 11. IDDM: day to day management.
    Samal KC; Tripathy BB
    J Assoc Physicians India; 1997; Suppl 1():21-9. PubMed ID: 11235630
    [No Abstract]   [Full Text] [Related]  

  • 12. Physiological considerations as a guide to the rational use of insulin.
    Ewart R
    J Ky Med Assoc; 1986 Mar; 84(3):104-7. PubMed ID: 3514777
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diabetes mellitus type II: when convert to insulin?].
    Bianda TL; Spinas GA
    Praxis (Bern 1994); 1997 Sep; 86(38):1453-7. PubMed ID: 9381045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intensified insulin therapy in type I diabetes: when and how?].
    Martin S
    Z Arztl Fortbild Qualitatssich; 1998 Sep; 92(7):475-80. PubMed ID: 9842692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes.
    Porcellati F; Rossetti P; Ricci NB; Pampanelli S; Torlone E; Campos SH; Andreoli AM; Bolli GB; Fanelli CG
    Diabetes Care; 2007 May; 30(5):1261-3. PubMed ID: 17303785
    [No Abstract]   [Full Text] [Related]  

  • 16. [Unanticipated sequelae of mountaineering: blood glucose suddenly on zigzag course].
    Achermann F
    MMW Fortschr Med; 2009 Apr; 151(14):15. PubMed ID: 19504835
    [No Abstract]   [Full Text] [Related]  

  • 17. [Reliable and new aspects of insulin therapy].
    Walter H
    Z Gesamte Inn Med; 1993 Mar; 48(3):135-9. PubMed ID: 8475637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.
    Ashwell SG; Gebbie J; Home PD
    Diabet Med; 2006 Aug; 23(8):879-86. PubMed ID: 16911626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting and postprandial plasma glucose and peripheral insulin levels in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus subjects during continuous intraperitoneal versus subcutaneous insulin delivery.
    Hermans MP; van Ypersele de Strihou M; Ketelslegers JM; Squifflet JP; Buysschaert M
    Transplant Proc; 1995 Dec; 27(6):3329-30. PubMed ID: 8539974
    [No Abstract]   [Full Text] [Related]  

  • 20. [Exercise, foods and bathing during insulin therapy].
    Kishikawa H; Soejima H; Tamama Y; Taguchi T; Araki E; Shichiri M
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():483-9. PubMed ID: 12430273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.